CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - July 20, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Rite Aid Continues Expansion of Coronavirus Testing Sites
by Zacks Equity Research
Rite Aid (RAD) is aggressively expanding COVID-19 testing locations by adding 161 more sites in order to curb the effects of coronavirus.
CVS Health (CVS) Stock Moves -0.05%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $62.62, moving -0.05% from the previous trading session.
Will Walmart's (WMT) Foray in Health Insurance be a Bane?
by Zacks Equity Research
Walmart's (WMT) penetration in the health insurance industry may intensify competition in the profitable MA market.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income - July 08, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Buy Beaten-Down Walgreens (WBA) Stock Ahead of Earnings?
by Benjamin Rains
Walgreens reports its Q3 FY20 financial results before the opening bell on Thursday, July 9. The question is should investors consider buying shares of the struggling pharmacy chain?
Can CVS Health (CVS) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $64.97, moving +0.85% from the previous trading session.
3 Top Dividend Stocks to Maximize Your Retirement Income - June 30, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
UnitedHealthcare'sTeledentistry Launch to Boost Oral Health
by Zacks Equity Research
UnitedHealth Group's (UNH) business - UnitedHealthcare - provides access to teledentistry option for its members in a bid to solve their oral health issues virtually.
CVS Health Offers Coronavirus Testing for Students, Businesses
by Zacks Equity Research
CVS Health (CVS) is increasing access to COVID-19 testing options as mass unlocking takes place throughout the nation.
CVS Health (CVS) Stock Moves -1.94%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $63.18, moving -1.94% from the previous trading session.
3 Investing Facts About Required Minimum Distributions You Need to Know - June 24, 2020
by Zacks Equity Research
Like many investors, you're likely aiming to build a comfortable nest egg to ensure a comfortable retirement. Make sure you know all about what financial planners dub the accumulation and distribution phases of retirement planning.
3 Top Dividend Stocks to Maximize Your Retirement Income - June 23, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Is CVS Health (CVS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $64.49 in the latest trading session, marking a -0.78% move from the prior day.
The Zacks Analyst Blog Highlights: Merck, CVS Health, Morgan Stanley, Applied Materials and Enterprise Products Partners
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Merck, CVS Health, Morgan Stanley, Applied Materials and Enterprise Products Partners
Top Stock Reports for Merck, CVS & Morgan Stanley
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Merck (MRK), CVS Health (CVS) and Morgan Stanley (MS).
Centene Raises 2020 EPS Guidance Despite Market Volatility
by Zacks Equity Research
Centene (CNC) unveils 2020 outlook reflecting its growing medical membership, which bodes well for investors.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $64.15, moving +1.57% from the previous trading session.
Rite Aid Adds More Testing Sites in Fight Against Coronavirus
by Zacks Equity Research
Rite Aid (RAD) is aggressively expanding COVID-19 testing locations by adding 21 more sites in order to curb the effects of coronavirus.
Telehealth Poised for Long-Term Growth Post Coronavirus
by Zacks Equity Research
Telehealth is here to stay for the long haul, given the changes prompted by COVID-19.
Pharmacies & Drug Stores Outlook Dull Amid Coronavirus Crisis
by Urmimala Biswas
Amid the coronavirus-led worldwide sales disruption, the retail pharmacy and drug store industry is witnessing a bloodbath.
UnitedHealth to Aid Eligible Medicaid Members in Kentucky
by Zacks Equity Research
UnitedHealth (UNH) and Commonwealth of Kentucky intends to improve health outcomes of Medicaid members in Kentucky, where it already has a strong presence.
U.S. Job Losses See Revival in May: Here's What It Means
by Zacks Equity Research
The job market is on the mend as lockdowns are eased and businesses gradual reopen. May numbers surpass all expectations, indicating the start of an economic revival from the coronavirus crisis.